Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial

被引:0
|
作者
Xuedong An
Bo Peng
Xiaodong Huang
Hongmei Jiang
Zhang’e Xiong
Hong Zhang
Fengmei Lian
Yuanming Ba
Xiaolin Tong
机构
[1] Guang’an Men Hospital of China Academy of Chinese Medical Sciences,
[2] Wuhan Third Hospital,undefined
[3] Hubei Provincial Hospital of Traditional Chinese Medicine,undefined
来源
关键词
Convalescent COVID-19; Ludangshen oral liquid; Traditional Chinese medicine; Digestive function; Randomized controlled trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Pentoxifylline in ALS - A double-blind, randomized, multicenter, placebo-controlled trial
    Meininger, V
    Asselain, B
    Guillet, P
    Leigh, PN
    Ludolph, A
    Lacomblez, L
    Robberecht, W
    [J]. NEUROLOGY, 2006, 66 (01) : 88 - 92
  • [22] Budesonide treatment for collagenous colitis:: A randomized, double-blind, placebo-controlled, multicenter trial
    Miehlke, S
    Heymer, P
    Bethke, B
    Bästlein, E
    Meier, E
    Bartram, HP
    Wilhelms, G
    Lehn, N
    Dorta, G
    Delarive, J
    Tromm, A
    Bayerdörffer, E
    Stolte, M
    [J]. GASTROENTEROLOGY, 2002, 123 (04) : 978 - 984
  • [23] Oral Glutathione and Growth in Cystic Fibrosis: A Multicenter, Randomized, Placebo-controlled, Double-blind Trial
    Bozic, Molly
    Goss, Christopher H.
    Tirouvanziam, Rabindra M.
    Baines, Arthur
    Kloster, Margaret
    Antoine, Liebe
    Borowitz, Drucy
    Schwarzenberg, Sarah Jane
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 71 (06): : 771 - 777
  • [24] Oral budenosid is highly effective in the treatment of collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial
    Miehlke, S
    Heymer, P
    Ochsenkuehn, T
    Baestlein, E
    Yarian, G
    Morgner, A
    Kirsch, C
    Dorta, G
    Tromm, A
    Mueller, H
    Stolte, M
    Bayerdoerffer, E
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A40 - A40
  • [25] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Alpha-1 Antitrypsin for ARDS Secondary to Severe COVID-19
    Mcelvaney, O.
    McEvoy, N.
    Boland, F.
    Mcelvaney, O. F.
    Hogan, G.
    Donnelly, K.
    Friel, O.
    Clarke, J.
    Fraughen, D.
    Murphy, M. P.
    Carroll, T. P.
    Geoghegan, P.
    Martin-Loeches, I.
    Mcelvaney, N. G.
    Curley, G. F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [26] Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
    Aman, Jurjan
    Duijvelaar, Erik
    Botros, Liza
    Kianzad, Azar
    Schippers, Job R.
    Smeele, Patrick J.
    Azhang, Sara
    Bartelink, Imke H.
    Bayoumy, Ahmed A.
    Bet, Pierre M.
    Boersma, Wim
    Bonta, Peter, I
    Boomars, Karin A. T.
    Bos, Lieuwe D. J.
    Bragt, Job J. M. H. van
    Braunstahl, Gert-Jan
    Celant, Lucas R.
    Eger, Katrien A. B.
    Geelhoed, J. J. Miranda
    Glabbeek, Yurika L. E. van
    Grotjohan, Hans P.
    Hagens, Laura A.
    Happe, Chris M.
    Hazes, Boaz D.
    Heunks, Leo M. A.
    Heuvel, Michel van den
    Hoefsloot, Wouter
    Hoek, Rianne J. A.
    Hoekstra, Romke
    Hofstee, Herman M. A.
    Juffermans, Nicole P.
    Kemper, E. Marleen
    Kos, Renate
    Kunst, Peter W. A.
    Lammers, Ariana
    Lee, Ivo van der
    Lee, E. Laurien van der
    Zee, Anke-Hilse Maitland-van der
    Asam, Pearl F. M. Mau
    Mieras, Adinda
    Muller, Mirte
    Neefjes, Elisabeth C. W.
    Nossent, Esther J.
    Oswald, Laurien M. A.
    Overbeek, Maria J.
    Pamplona, Carolina C.
    Paternotte, Nienke
    Pronk, Niels
    Raaf, Michiel A. de
    Raaij, Bas F. M. van
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (09): : 957 - 968
  • [27] Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial
    Shahbaznejad, Leila
    Davoudi, Alireza
    Eslami, Gohar
    Markowitz, John S.
    Navaeifar, Mohammad Reza
    Hosseinzadeh, Fatemeh
    Movahedi, Faeze Sadat
    Rezai, Mohammad Sadegh
    [J]. CLINICAL THERAPEUTICS, 2021, 43 (06) : 1007 - 1019
  • [28] Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients
    De Boeck, Ilke
    Cauwenberghs, Eline
    Spacova, Irina
    Gehrmann, Thies
    Eilers, Tom
    Delanghe, Lize
    Wittouck, Stijn
    Bron, Peter A.
    Henkens, Tim
    Gamgami, Imane
    Simons, Alix
    Claes, Ingmar
    Marien, Joachim
    Arien, Kevin K.
    Bakokimi, Diana
    Loens, Katherine
    Jacobs, Kevin
    Ieven, Margareta
    Bruijning-Verhagen, Patricia
    Delputte, Peter
    Coenen, Samuel
    Verhoeven, Veronique
    Lebeer, Sarah
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [29] Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
    Anan Manomaipiboon
    Kittisak Pholtawornkulchai
    Sujaree Poopipatpab
    Swangjit Suraamornkul
    Jakravoot Maneerit
    Wiroj Ruksakul
    Uraporn Phumisantiphong
    Thananda Trakarnvanich
    [J]. Trials, 23
  • [30] Bromhexine for Post-exposure COVID-19 Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial
    Tolouian, Ramin
    Moradi, Omid
    Mulla, Zuber D.
    Ziaie, Shadi
    Haghighi, Mehrdad
    Esmaily, Hadi
    Amini, Hossein
    Hassanpour, Rezvan
    Poorheidar, Elham
    Kouchek, Mehran
    Manafi-Rasi, Alireza
    Sali, Shahnaz
    Abolghasemi, Sara
    Tehrani, Shabnam
    Tolouian, Audrey C.
    Zali, Alireza
    Sistanizad, Mohammad
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2022, 15 (08)